At a glance
ClinicalIndex Comparison RecordN/ACompleted· 167 enrolled
Drug / intervention
Sotalol Injectiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Evaluation Analysis and Kinetics of IV Sotalol
In Brief
An observational study evaluating Sotalol Injection for Atrial Arrhythmia. Completed, enrolled 167 participants across 1 site.
Detailed Summary
In a cohort of patients electively treated for atrial arrhythmia with IV sotalol (initiation or dose escalation), this study will describe patient characteristics, short-term safety and efficacy, electrocardiographic monitoring, and PK and PD parameters (in a subset) associated with IV dosing approach.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Arrhythmia
CountriesUnited States
CollaboratorsAltaThera Pharmaceuticals, LLC
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartFeb 2022
First PostedFeb 2022
Primary CompletionAug 2023
TodayJul 2026
First PostedFeb 18, 2022
Enrollment StartFeb 4, 2022
Primary CompletionAug 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.4 years ago
Interventions
Sotalol Injectiondrug
Standard of care IV sotalol infusion for atrial arrhythmias